NCT04630379View on ClinicalTrials.gov

Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 13, 2018

Primary Completion Date

June 13, 2019

Study Completion Date

August 31, 2020

Conditions
GlioblastomaMalignant GliomaWHO Grade III Glioma
Interventions
OTHER

Palliative Therapy

Visit with palliative care team

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Supportive Care

Visit with neuro-oncologist

OTHER

Survey Administration

Complete survey

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT04630379 - Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers | Biotech Hunter | Biotech Hunter